home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Amplification Of Estrogen Receptor Gene In Breast Cancer

  April, 19 2007 8:18
your information resource in human molecular genetics
Nearly two-thirds of breast tumors have extra copies of the gene encoding one form of the estrogen receptor ESR1, suggests a study published online in Nature Genetics.

A small-scale initial study shows that women treated with tamoxifen, which blocks the activity of the estrogen receptor, survive longer if their tumor has this gene amplification.

Estrogen receptor expression is one of the most important known factors in the development of breast cancer, and assessing its status is important for determining the use of anti-estrogen receptor therapies like tamoxifen. Ronald Simon and colleagues examined more than 2,000 breast cancer samples for evidence of amplification of ESR1, and detected it in nearly two-thirds of the tumors. In a small follow-up study of 175 women with breast cancer who were being treated with tamoxifen, they found that women with the amplification survived longer than those who did not, even though the tumors in both groups of women expressed ESR1. The authors suggest that ESR1 amplification may identify a subgroup of breast cancers that would be particularly likely to respond to anti-estrogen therapy.

Author contact:

Ronald Simon (University Medical Center Hamburg Eppendorf, Germany)
E-mail: r.simon@uke.uni-hamburg.de

Abstract available online.

(C) Nature Genetics press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.